默克尔细胞癌:美国当前发病率及基于人口老龄化的预测增长
基于SEER-18数据库6600例默克尔细胞癌(MCC)病例分析,2000-2013年美国MCC病例数增长95%,2013年发病率为0.7例/10万人年(2488例/年),且随年龄呈指数增长。因婴儿潮一代老龄化,预测2020年和2025年新增病例分别达2835例/年和3284例/年。
要点
- 2000-2013年美国MCC病例数增长95%,高于黑色素瘤(57%)和实体瘤(15%)。
- MCC发病率随年龄指数增长:40-44岁为0.1例/10万人年,≥85岁为9.8例/10万人年。
- 预测2025年美国MCC新增病例将达3284例/年,老龄化是主要驱动因素。
核心结论
- 美国人口老龄化正驱动MCC新增病例快速增加,需扩大对MCC诊断和管理的认知。
研究设计与样本
- 基于SEER-18登记数据库的6600例MCC病例,使用美国人口普查数据进行年龄和性别调整后的发病趋势预测。
主要发现
- 2000-2013年实体癌病例数增长15%,黑色素瘤增长57%,MCC增长95%。
- 2013年美国MCC发病率为0.7例/10万人年,对应2488例/年。
- MCC发病率随年龄指数增长:40-44岁0.1例/10万人年,60-64岁1.0例/10万人年,≥85岁9.8例/10万人年。
- 预测美国MCC新增病例2020年达2835例/年,2025年达3284例/年。
临床怎么用
- 临床医生应提高对MCC的诊断意识,尤其对老年患者皮肤病变保持警惕。
- 鉴于MCC治疗格局快速演变,需关注诊断和管理的最新进展。
局限性
- 研究假设年龄调整发病率将趋于稳定,因此预测的新增病例数可能被低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Merkel cell carcinoma (MCC) incidence rates are rising and strongly age-associated, relevant for an aging population. OBJECTIVE: Determine MCC incidence in the United States and project incident cases through the year 2025. METHODS: Registry data were obtained from the SEER-18 Database, containing 6600 MCC cases. Age- and sex-adjusted projections were generated using US census data. RESULTS: During 2000-2013, the number of reported solid cancer cases increased 15%, melanoma cases increased 57%, and MCC cases increased 95%. In 2013, the MCC incidence rate was 0.7 cases/100,000 person-years in the United States, corresponding to 2488 cases/year. MCC incidence increased exponentially with age, from 0.1 to 1.0 to 9.8 (per 100,000 person-years) among age groups 40-44 years, 60-64 years, and ≥85 years, respectively. Due to aging of the Baby Boomer generation, US MCC incident cases are predicted to climb to 2835 cases/year in 2020 and 3284 cases/year in 2025. LIMITATIONS: We assumed that the age-adjusted incidence rate would stabilize, and thus, the number of incident cases we projected might be an underestimate. CONCLUSION: An aging population is driving brisk increases in the number of new MCC cases in the United States. This growing impact combined with the rapidly evolving therapeutic landscape warrants expanded awareness of MCC diagnosis and management.
引用
- Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2017. PMID: 29102486. doi:10.1016/j.jaad.2017.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。